← All Investors
LONGBOARD PHARMACEUTICALS IN
Holders
0
Combined Value
$0
Combined Shares
0
Investor Activity Chart
Quarterly buys (▲) and sells (▼) by tracked investors. Click a marker to view that investor's portfolio; hover for details. Price line is implied from 13F filings (value ÷ shares), not market data.
Held By
Tracked investors currently holding this security, based on each investor's most recent 13F filing. Gain compares the current market price to each investor's estimated average buy price.
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|
No tracked investors currently hold this security.
Recent Activity
Latest position changes by tracked investors. Prices are estimates implied from 13F filings.
| Quarter | Investor | Action | Est. Value | Est. Price |
|---|---|---|---|---|
| Q4 2024 | Andreas Halvorsen - Viking Global Investors | SOLD OUT | −$65.63M | ~$33.33 |
| Q3 2024 | Andreas Halvorsen - Viking Global Investors | BUY | +$10.33M | ~$33.33 |
| Q2 2024 | Andreas Halvorsen - Viking Global Investors | NEW BUY | +$44.84M | ~$27.03 |
Ownership History
Aggregate position across all tracked investors per quarter (options excluded). Implied price is the reported value divided by shares held.
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q3 2024 | 1 | 1,969,041 | +18.7% | $65.63M | $33.33 |
| Q2 2024 | 1 | 1,658,962 | — | $44.84M | $27.03 |